Assessment of sleep and breathing in adults with Prader-Willi syndrome: A case control series

Journal of Clinical Sleep Medicine

Volumn 3, Issue 7, 2007, Pages 713-718

  Yee, Brendon J ^a,b   Buchanan, Peter R ^a,b   Mahadev, Sri ^b   Banerjee, Dev ^a,b   Liu, Peter Y ^a   Phillips, Craig ^a   Loughnan, Georgina ^b   Steinbeck, Kate ^b,c   Grunstein, Ronald R ^a,b  

^a WOOLCOCK INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c University of Sydney   (Australia)

Author keywords

Leptin; Nocturnal hypoxemia; Obesity hypoventilation syndrome; Obstructive sleeps apnea; Prader Willi syndrome

Indexed keywords

LEPTIN; OXYHEMOGLOBIN;

ADULT; ARTICLE; BODY MASS; BREATHING PATTERN; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MALE; OBESITY HYPOVENTILATION SYNDROME; POLYSOMNOGRAPHY; PRADER WILLI SYNDROME; REM SLEEP; SLEEP APNEA SYNDROME; SLEEP PATTERN; SLEEP TIME;

EID: 38849146552     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.27028     Document Type: Article

References (62)

1. Smith A, Egan J, Ridley G, et al. Birth prevalence of Prader-Willi syndrome in Australia. Arch Dis Child 2003;88:263-4.
2. Burd L, Vesely B, Martsolf J, Kerbeshian J. Prevalence study of Prader-Willi syndrome in North Dakota. Am J Med Genet 1990;37:97-9.
3. Vogels A, Van Den Ende J, Keymolen K, et al. Minimum prevalence, birth incidence and cause of death for Prader-Willi syndrome in Flanders. Eur J Hum Genet 2004;12:238-40.
4. Akefeldt A, Gillberg C, Larsson C. Prader-Willi syndrome in a Swedish rural county: epidemiological aspects. Dev Med Child Neurol 1991;33:715-21.
5. Holm VA, Cassidy SB, Butler MG, et al. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 1993;91:398-402.
6. Couper R. Prader-Willi syndrome. J Paediatr Child Health 1999;35:331-4.
7. Richdale AL, Cotton S, Hibbit K. Sleep and behaviour disturbance in Prader-Willi syndrome: a questionnaire study. J Intellect Disabil Res 1999;43:380-92.
8. Hiroe Y, Inoue Y, Higami S, Suto Y, Kawahara R. Relationship between hypersomnia and respiratory disorder during sleep in Prader-Willi syndrome. Psychiatry Clin Neurosci 2000;54:323-5.
9. Manni R, Politini L, Nobili L, et al. Hypersomnia in the Prader Willi syndrome: clinical-electrophysiological features and underlying factors. Clin Neurophysiol 2001;112:800-5.
10. Clift S, Dahlitz M, Parkes JD. Sleep apnoea in the Prader-Willi syndrome. J Sleep Res 1994; 3:121-6.
11. Richards A, Quaghebeur G, Clift S, Holland A, Dahlitz M, Parkes D. The upper airway and sleep apnoea in the Prader-Willi syndrome. Clin Otolaryngol Allied Sci 1994;19:193-7.
12. Hertz G, Cataletto M, Feinsilver SH, Angulo M. Developmental trends of sleep-disordered breathing in Prader-Willi syndrome: the role of obesity. Am J Med Genet 1995 27;56:188-90.
13. Hart PS. Salivary abnormalities in Prader-Willi syndrome. Ann N Y Acad Sci 1998;842:125-31.
14. Wharton RH, Loechner KJ. Genetic and clinical advances in Prader-Willi syndrome. Curr Opin Pediatr 1996;8:618-24.
15. State MW, Dykens EM. Genetics of childhood disorders: XV. Prader-Willi syndrome: genes, brain, and behavior. J Am Acad Child Adolesc Psychiatry 2000;39:797-800.
16. Muscatelli F, Abrous DN, Massacrier A, et al. Disruption of the mouse Necdin gene results in hypothalamic and behavioral alterations reminiscent of the human Prader-Willi syndrome. Hum Mol Genet 2000;9:3101-10.
17. Glenn CC, Nicholls RD, Robinson WP, et al. Modification of 15q11-q13 DNA methylation imprints in unique Angelman and Prader-Willi patients. Hum Mol Genet 1993;2:1377-82.
18. Reed ML, Leff SE. Maternal imprinting of human SNRPN, a gene deleted in Prader-Willi syndrome. Nat Genet 1994;6:163-7.
19. MacDonald HR, Wevrick R. The necdin gene is deleted in Prader-Willi syndrome and is imprinted in human and mouse. Hum Mol Genet 1997 Oct;6(11):1873-8.
20. Burman P, Ritzen EM, Lindgren AC. Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. Endocrine reviews 2001;22:787-99.
21. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000;19:479-82.
22. Nieto F, Young T, Lind B, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000;283:1829-36.
23. Young T, Peppard P, Palta M, et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997;157:1746-52.
24. Grote L, Ploch T, Heitmann J, Knaack L, Penzel T, Peter J. Sleep-related breathing disorder is an independent risk factor for systemic hypertension. Am J Respir Crit Care Med 1999;160:1875-82.
25. Bixler E, Vgontzas A, Lin H, et al. Association of hypertension and sleep-disordered breathing. Arch Intern Med 2000;160:2289-95.
26. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002, 2002;165:1217-39.
27. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005, 2005;353:2034-41.
28. Dhillon S, Chung SA, Fargher T, Huterer N, Shapiro CM. Sleep apnea, hypertension, and the effects of continuous positive airway pressure. Am J Hypertens 2005;18:594-600.
29. Doherty LS, Kiely JL, Swan V, McNicholas WT. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 2005;127:2076-84.
30. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-53.
31. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003;107:68-73.
32. Smith A, Loughnan G, Steinbeck K. Death in adults with Prader-Willi syndrome may be correlated with maternal uniparental disomy. J Med Genet 2003 40:e63.
33. Schrander-Stumpel CT, Curfs LM, Sastrowijoto P, Cassidy SB, Schrander JJ, Fryns JP. Prader-Willi syndrome: causes of death in an international series of 27 cases. Am J Med Genet A 2004 1;124:333-8.
34. Stevenson DA, Anaya TM, Clayton-Smith J, et al. Unexpected death and critical illness in Prader-Willi syndrome: report of ten individuals. Am J Med Genet A 2004;124:158-64.
35. Nixon GM, Brouillette RT. Sleep and breathing in Prader-Willi syndrome. Pediatr Pulmonol 2002;34:209-17.
36. Lohmann TG, Roche A, Martello R. Anthrometrics standardization reference manual. Human Kinetics; 1988.
37. Rechtschaffen A, Kales A, eds. A Manual of Standardized Terminology, Techniques, and Scoring System for Sleep Stages of Human Subjects. Los Angeles: Brain Information Service/Brain Research Institute, UCLA; 1968.
38. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22:667-89.
39. Ledbetter DH, Riccardi VM, Airhart SD, Strobel RJ, Keenan BS, Crawford JD. Deletions of chromosome 15 as a cause of the Prader-Willi syndrome. N Engl J Med 1981;304:325-9.
40. Butler MG. Prader-Willi syndrome: current understanding of cause and diagnosis. Am J Med Genet 1990; 35:319-32.
41. Olson AL, Zwillich C. The obesity hypoventilation syndrome. Am J Med 2005;118:948-56.
42. Conus F, Allison DB, Rabasa-Lhoret R, et al. Metabolic and behavioral characteristics of metabolically obese but normal-weight women. J Clin Endocrinol Metab 2004; 89: 5013-20.
43. Mallory GB, Jr., Fiser DH, Jackson R. Sleep-associated breathing disorders in morbidly obese children and adolescents. J Pediatr 1989;115:892-7.
44. Hakonarson H, Moskovitz J, Daigle KL, Cassidy SB, Cloutier MM. Pulmonary function abnormalities in Prader-Willi syndrome. J Pediatr 1995;126:565-70.
45. van Mil EA, Westerterp KR, Gerver WJ, et al. Energy expenditure at rest and during sleep in children with Prader-Willi syndrome is explained by body composition. Am J Clin Nutr 2000;71:752-6.
46. van Mil EG, Westerterp KR, Kester AD, et al. Activity related energy expenditure in children and adolescents with Prader-Willi syndrome. Int J Obes Relat Metab Disord 2000;24:429-34.
47. Arens R, Gozal D, Omlin KJ, Livingston FR, Liu J, Keens TG, et al. Hypoxic and hypercapnic ventilatory responses in Prader-Willi syndrome. J Appl Physiol 1994;77:2224-30.
48. Gozal D, Arens R, Omlin KJ, Ward SL, Keens TG. Absent peripheral chemosensitivity in Prader-Willi syndrome. J Appl Physiol 1994;77:2231-6.
49. Arens R, Gozal D, Burrell BC, et al. Arousal and cardiorespiratory responses to hypoxia in Prader-Willi syndrome. Am J Respir Crit Care Med 1996;153:283-7.
50. Livingston FR, Arens R, Bailey SL, Keens TG, Ward SL. Hypercapnic arousal responses in Prader-Willi syndrome. Chest 1995;108:1627-31.
51. Nowbar S, Burkart KM, Gonzales R, et al. Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome. Am J Med 2004;116:1-7.
52. Laaban JP, Chailleux E. Daytime hypercapnia in adult patients with obstructive sleep apnea syndrome in France, before initiating nocturnal nasal continuous positive airway pressure therapy. Chest 2005;127: 710-5.
53. Vgontzas AN, Kales A, Seip J, et al. Relationship of sleep abnormalities to patient genotypes in Prader-Willi syndrome. Am J Med Genet 1996; 67:478-82.
54. Hertz G, Cataletto M, Feinsilver SH, Angulo M. Sleep and breathing patterns in patients with Prader Willi syndrome (PWS): effects of age and gender. Sleep 1993;16:366-71.
55. Kuwajima T, Nishimura I, Yoshikawa K. Necdin promotes GABAergic neuron differentiation in cooperation with Dlx homeodomain proteins. J Neurosci 2006;26:5383-92.
56. Lee S, Walker CL, Karten B, et al. Essential role for the Prader-Willi syndrome protein necdin in axonal outgrowth. Hum Mol Genet 2005;14:627-37.
57. Kuwako K, Taniura H, Yoshikawa K. Necdin-related MAGE proteins differentially interact with the E2F1 transcription factor and the p75 neurotrophin receptor. J Biol Chem 2004;279:1703-12.
58. Talebizadeh Z, Butler MG. Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects. Clin Genet 2005;67:230-9.
59. O'Donnell C P, Schaub CD, Haines AS, et al. Leptin prevents respiratory depression in obesity. Am J Respir Crit Care Med 1999;159:1477-84.
60. Goldstone AP, Patterson M, Kalingag N, et al. Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma. J Clin Endocrinol Metab 2005;90:2681-90.
61. Choe YH, Song SY, Paik KH, et al. Increased density of ghrelin-expressing cells in the gastric fundus and body in Prader-Willi syndrome. J Clin Endocrinol Metab 2005;90:5441-5.
62. Young T, Peppard PE, Taheri S. Excess weight and sleep disordered breathing. J Appl Physiol 2005;99: 1592-99.